2024 Incentive Grant Recipient

2024 Incentive Grant Recipient: Shelby Rummage, PharmD


Project Proposal: The Impact of Targeted Medication Review by Community Pharmacists on the Prescription of Migraine Preventive Therapy in Two Locations of a Large Community Pharmacy Chain

Shelby Rummage is a Community PGY-1 Resident with the University of Tennessee Health Science Center and Kroger Pharmacy in Nashville, TN. She attended Belmont University.     

“Migraine disorder is a common, debilitating neurological condition that is estimated to affect nearly 10% of the global population. Historically, migraine preventive therapy has been underutilized due to a variety of factors, including but not limited to undesirable side effects, insufficient efficacy, and inconvenience of regimen. Newer medications have become available that improve upon many of these concerns but may come with barriers to treatment such as higher cost and lack of insurance coverage. Since community pharmacists are one of the most accessible healthcare professionals and they possess the knowledge to help work through some of these barriers, they may be able to play an important role in facilitating the initiation of migraine preventive therapy for eligible patients.”

"I came across a startling statistic: It’s estimated that nearly 40% of patients with migraine could potentially benefit from migraine preventive therapy, but only 3-13% of those patients receive it. As someone who is well-aware of how debilitating headaches can be, I wanted to explore what community pharmacists can do to increase the number of eligible patients receiving migraine preventive therapy. Community pharmacist involvement in the initiation of migraine preventive therapy has not been evaluated in the literature, so I hope this project can serve as framework for future migraine-focused services within community pharmacy."

"I’m thrilled and grateful to be an Incentive Grant recipient. This funding will be used to further define and explore the enhanced role of the community pharmacist, which will ultimately help patients live healthier lives."